Results 221 to 230 of about 53,729,253 (423)

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial

Molecular Oncology, EarlyView.
Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate
Luka Tandaric, Annika Auranen, Katrin Kleinmanns, René DePont Christensen, Liv Cecilie Vestrheim Thomsen, Cara Ellen Wogsland, Emmet McCormack, Johanna Mäenpää, Kristine Madsen, Karen Stampe Petersson, Mansoor Raza Mirza, Line Bjørge   +11 more
wiley   +1 more source

Changes in the trajectories of drug-free friendships and substance use among a cohort of individuals with multiple substance use disorders. [PDF]

Nordisk Alkohol Nark
Moe FD, Tjora T, Moltu C, McKay JR, Hagen E, Erga A, Bjornestad J.   +6 more
europepmc   +1 more source

Adsorption gas chromatography using water vapor as the carrier gas for organic substances containing oxygen

, 1967
Akira Nonaka
openalex   +2 more sources

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes

Molecular Oncology, EarlyView.
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane, Jérôme Ambroise, Cédric van Marcke, Mieke Van Bockstal, Martine Berlière, Christine Galant, Hélène Dano, Médina Lougué, Elena Benidovskaya, Guy Jerusalem, Vincent Bours, Claire Josse, Jérôme Thiry, Aurélie Daumerie, Caroline Bouzin, Cyril Corbet, François P. Duhoux   +16 more
wiley   +1 more source

Substance Use Disorder [PDF]

, 2019
O'Horo, John C
core  

Polysubstance Use Is Not Synonymous With Poly Substance Use Disorder. [PDF]

Am J Public Health
Xu KY, Lin LA, Grucza RA.
europepmc   +1 more source

Studies on Carcinostatic Substances. XL. Application of Cell Counting Method to the Screening of Antitumor Substances using the in vitro-cultured Yoshida Sarcoma Cells.

, 1962
Ayako Moriwaki
openalex   +2 more sources

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer

Molecular Oncology, EarlyView.
We used whole exome and RNA‐sequencing to profile divergent genomic and transcriptomic landscapes of microsatellite stable (MSS) and microsatellite instable (MSI) colorectal cancer. Alterations were classified using a computational score for integrative cancer variant annotation and prioritization.
Efstathios‐Iason Vlachavas, Konstantinos Voutetakis, Vivian Kosmidou, Spyridon Tsikalakis, Spyridon Roditis, Konstantinos Pateas, Ryangguk Kim, Kymberleigh Pagel, Stephan Wolf, Gregor Warsow, Antonia Dimitrakopoulou‐Strauss, Georgios N. Zografos, Alexander Pintzas, Johannes Betge, Olga Papadodima, Stefan Wiemann   +15 more
wiley   +1 more source

Lung Transplantation From Donors With a History of Substance Use. [PDF]

Clin Transplant
Li D, Weinkauf J, Hirji A, Weatherald J, Varughese R, van den Bosch L, Lien D, Nagendran J, Halloran K.   +8 more
europepmc   +1 more source

A New Method for Extraction of Sedimented Humic Substances by Using Elution Column

, 1966
Ryoshi Ishiwatari, Takahisa Hanya
openalex   +2 more sources